Abstract:Abstract The randomized play-the winner (RPW) rule is very useful in clinical trials for patient allocation with two treatments. Wei (1979) introduces the generalized Friedman’s urn (GFU) model to clinical trials of K treatment (as an extension of the RPW). In this paper, we consider a general kind of adaptive designs, whose generations depend on an estimated parameter, for example the estimated success rate. Using this kind of adaptive designs, more informations of previous stages are used to update the model at each stage, and more patients may be assigned to a better treatment than the RPW rule and Wei’s rule. The strong consistency and the asymptotic normalities are established for both the urn composition and the number of patients assigned to each treatment. A adaptive design proposed by Bai, Hu and Shen (2001) recently is a simple special example. 1 Introduction and main results 1.1 Introduction and the Model In comparing of K treatments, suppose that patients are available for the study sequentially and must be assigned to a treatment group immediately upon arrival. Adaptive designs, which use accumulating information to assign patients to treatments, tend to assign more patients to better treatments in clinical trials. A typical probability model for adaptive clinical trials is the Generalized Friedman’s Urn (GFU) model (also named as Generalized P´olya Urn (GPU) in literature). The model is described as follows. Consider an urn containing particles of K types, respectively representing K ’treatments’ in a clinical trial. The patients are to be allocated sequentially to the treatments. At the beginning, the urn contains Y0 = (Y0;1;:::;Y0;K) particles, where Y0;k > 0 denotes the number of particles of type k, k = 1;:::;K. At stage i, i = 1;2;:::, a particle is drawn from the urn and replaced. If the particle is of type k, then the treatment k is assigned to the i-th patient, k = 1;:::;K, i = 1;2;:::. After observing a random variables »i;k which may be considered as the response of the i-th patient on the treatment k, an additional Di(k;q;»i;k) particles of type q,

Approximation to the optimal allocation for response adaptive designs

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

Are adaptive allocation designs beneficial for improving power in binary response trials?

Efficient Randomized-Adaptive Designs

Asymptotically best response-adaptive randomization procedures☆

The asymptotic theorems of adaptive designs for clinical trials with generations depending on the estimated success rates

Optimal Marker-Adaptive Designs for Targeted Therapy Based on Imperfectly Measured Biomarkers

Asymptotic Results on a Class of Adaptive Multi-Treatment Designs

Adaptive Allocation Theory in Clinical Trials

Statistical Inference of Adaptive Randomized Clinical Trials for Personalized Medicine

A two armed optimal response adaptive randomization for ordinal categorical responses with possible misclassification

Optimum designs for clinical trials in personalized medicine when response variance depends on treatment

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

Adaptive Clinical Trials: Exploiting Sequential Patient Recruitment and Allocation

An Adaptive Trial Design to Optimize Dose-Schedule Regimes with Delayed Outcomes

Nonparametric Response-Adaptive Randomization for Continuous Responses

Optimal Biomarker-Guided Design for Targeted Therapy with Imperfectly Measured Biomarkers

Optimal Adaptive Experimental Design for Estimating Treatment Effect

Model-based optimal randomization procedure for treatment–covariate interaction tests

ST ] 1 7 O ct 2 00 6 ASYMPTOTIC PROPERTIES OF COVARIATE-ADJUSTED ADAPTIVE DESIGNS

A Probability Based Method for Selecting the Optimal Personalized Treatment from Multiple Treatments.